
Ilkka Helanterä
620 posts

Ilkka Helanterä
@helantera
MD, PhD, Adj. Prof; Transplant Nephrologist in Helsinki University Hospital 🇫🇮; Associate editor in Am J Transplant and Transplant Int









As the end of the year approaches, consider applying for the AJT Editorial Fellowship Program. The Editorial Fellowship is a year-long editorial experience in the publication and peer review process to fellows and junior faculty in transplant-related fields.

As the end of the year approaches, consider applying for the AJT Editorial Fellowship Program. The Editorial Fellowship is a year-long editorial experience in the publication and peer review process to fellows and junior faculty in transplant-related fields.










Today MD @JuuliaGras defended her doctoral thesis titled Studies on complications of kidney and SPK transplantation in Finland. Thanks to opponent @KamarNassim for keeping the discussion Interesting. And congratulations to supervisors @helantera @MarkoLempinen

12/12 Older recipients derive significant benefits from LD, highlighting the importance of evaluating candidates independently from age! ☝️Paired exchange offers a viable opportunity to improve age matching. Register here go.esot.org/ti_jc_18nov2024 and see you on the 18th 5 pm CEST!


Prognostic models are becoming increasingly relevant in clinical trials as potential surrogate endpoints, and for patient management as clinical decision support tools. This study found that competing and noncompeting risk models performed similarly in predicting long-term kidney graft failure. bit.ly/JASN0517 @alexhertig @DivardG @jfriedo @mcoemans1 @MCrespoBarrio @mnaesens




